Microbiome Diagnostics Market is Expected to Reach $300 million | MarketsandMarkets™

Chicago, March 13, 2024 (GLOBE NEWSWIRE) — Microbiome Diagnostics market in terms of revenue was estimated to be worth $146 million in 2023 and is poised to reach $300 million by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The microbiome diagnostics market is driven by a rise in the collaborative efforts between the microbiome industry and academia for microbiome research and the growing demand for personalized medicine.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132581140

Microbiome Diagnostics Market Scope:

Report Coverage Details
Market Revenue in 2023 $146 million
Estimated Value by 2028 $300 million
Growth Rate Poised to grow at a CAGR of 15.5%
Market Size Available for 2022–2028
Forecast Period 2023–2028
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technology, Sample, Application, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, Rest of the World
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Increased collaboration of key players and small innovative companies to work on new microbiome technologies
Key Market Driver Collaborative efforts between the microbiome industry and academia for microbiome research

The incidence of chronic diseases across the globe has increased significantly. Microbiomes have major applications in the diagnosis of several chronic conditions, such as obesity and diabetes, and thus the prevalence of these conditions is expected to drive the demand for microbiome diagnostic products in the coming years. For instance, Globally, the number of patients suffering from diabetes is expected to grow from ∼537 million in 2021 to almost 783 million by 2045. (Source: International Diabetes Federation).

Based on products, the microbiome diagnostics market is segmented into reagents & kits and instruments. Reagents & kits accounted for the largest share of the market in 2022. The large share of this product segment can primarily be attributed to repeat purchases and consumption of reagents & kits for diagnostic procedures as compared to the instruments, which have a longer shelf time and can be used for multiple procedures.

The microbiome diagnostics market is segmented based on technology into 16s rRNA sequencing, shotgun metagenomics, metatranscriptomics and other technologies. 16s rRNA accounted for the largest share of the microbiome diagnostics market in 2022. The high accuracy and affordability offered by 16S rRNA sequencing, and the growing number of microbiomic research activities to identify and classify various bacterial strains are driving the growth of the segment.

Based on samples, the microbiome diagnostics market is segmented into fecal, saliva, skin and other samples. In 2022, feces accounted for the largest share of the microbiome-based diagnostics market. This segment is also projected to register the highest CAGR during the forecast period, owing to the rising prevalence of disease and increasing microbiome research activities.
Based on applications, the microbiome diagnostics market is segmented into research applications, disease diagnostic applications. In 2022, the disease diagnostic application segment accounted for the largest share of the microbiome-based diagnostics market. The large share of this segment is due to the increasing prevalence of diseases, the increasing collaboration of industrial players and academic institutes to develop microbiome diagnostics.

Based on end users, the microbiome diagnostics market is segmented into hospitals, research institutes, pharmaceutical & biotechnology companies and other end users. Hospitals accounted for largest share of the microbiome diagnostics market in 2022. The significant share of the segment is primarily due to the rising prevalence of diseases.

The microbiome diagnostics market is segmented into four major regions: North America, Europe, the Asia Pacific, and Rest. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, owing to the demand for better healthcare services, and the rising prevalence of chronic.

Buy an Microbiome Diagnostics Industry Report (185 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=132581140

Microbiome Diagnostics market major players covered in the report, such as:

  • DNA Genotek (Canada)
  • Invivo Healthcare (UK)
  • Microba Life Sciences (US)
  • Genetic Analysis AS (Norway)
  • Metabiomics (US)
  • Teraomics (US)
  • Becton, Dickinson and Company (US)
  • BioMe Oxford Ltd (UK)
  • Viennalab Diagnostics (Austria)
  • Viome Life Sciences, Inc. (US)
  • Luxia Scientific (France)
  • DayTwo (US)
  • Sun Genomics (US)
  • Atlas Biomed (UK)
  • Quantbiome, Inc. (US)
  • GoodGut  (US)
  • Micronoma (US)
  • FlightPath Biosciences (US)
  • Microbiome Research Pvt.Ltd. (India)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132581140

This report categorizes the microbiome diagnostics market into the following segments and subsegments:

By Product

  • Reagents & Kits
  • Instruments

By Technology

  • 16S rRNA Sequencing
  • Shot Gun Metagenomics
  • Metatranscriptomics
  • Other Technology

By Sample

  • Faces
  • Saliva
  • Skin
  • Other Sample

By Application

  • Disease Diagnostics Application
    • Gastrointestinal Disorders
    • Metabolic Diseases
    • Other Application
  • Research Application

By End User

  • Hospitals
  • Academic and Research Institutes
  • Biotechnology and Pharmaceutical Companies

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132581140

Key Market Stakeholders:

  • Manufacturers and distributors of microbiome-based diagnostics products
  • Pharmaceutical and Biotechnology Companies
  • R & D centers
  • Diagnostic laboratories
  • Hospitals and clinics
  • Academic institutes
  • Research institutes
  • Market research and consulting firms

Report Objectives:

  • To define, describe, segment, and forecast the global microbiome diagnostics market by product, sample, application, end user and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall microbiome diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

Related Reports:

Chromatography Reagents Market

Pharmacogenomics Market

Epigenetics Market

Sterility Testing Market

Research Antibodies & Reagents Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/microbiome-diagnostics-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/microbiome-diagnostics.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy